Advertisement
Singapore markets close in 6 hours 53 minutes

  • Straits Times Index

    3,243.65
    -20.88 (-0.64%)
     

  • Nikkei

    38,330.33
    +127.96 (+0.33%)
     

  • Hang Seng

    18,394.09
    +80.23 (+0.44%)
     

  • FTSE 100

    8,354.05
    +40.38 (+0.49%)
     

  • Bitcoin USD

    61,505.45
    -1,148.17 (-1.83%)
     

  • CMC Crypto 200

    1,310.05
    +15.38 (+1.19%)
     

  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     

  • Dow

    39,056.39
    +172.13 (+0.44%)
     

  • Nasdaq

    16,302.76
    -29.80 (-0.18%)
     

  • Gold

    2,316.30
    -6.00 (-0.26%)
     

  • Crude Oil

    79.30
    +0.31 (+0.39%)
     

  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     

  • FTSE Bursa Malaysia

    1,606.71
    +1.96 (+0.12%)
     

  • Jakarta Composite Index

    7,088.79
    -34.82 (-0.49%)
     

  • PSE Index

    6,700.21
    +41.03 (+0.62%)
     

Teladoc (TDOC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Equity Research
·2-min read

For the quarter ended March 2024, Teladoc (TDOC) reported revenue of $646.13 million, up 2.7% over the same period last year. EPS came in at -$0.49, compared to -$0.37 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $636.98 million, representing a surprise of +1.44%. The company delivered an EPS surprise of -4.26%, with the consensus EPS estimate being -$0.47.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Teladoc performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • U.S. Integrated Care Members: 91.8 million versus the five-analyst average estimate of 89.85 million.

  • BetterHelp Paying Users: 0.42 million versus 0.43 million estimated by five analysts on average.

  • Chronic Care Program Enrollment: 1.12 million compared to the 1.13 million average estimate based on four analysts.

  • Average Revenue Per U.S. Integrated Care Member: $1.38 compared to the $1.38 average estimate based on four analysts.

  • Visits: 4,600,000 compared to the 5,056,574 average estimate based on two analysts.

  • Revenues by Segment- Teladoc Health Integrated Care: $377.11 million versus the seven-analyst average estimate of $370.07 million.

  • Revenues by Segment- BetterHelp: $269.02 million compared to the $267.37 million average estimate based on seven analysts.

  • Revenues by Segment- BetterHelp- Other Wellness Services: $5.31 million versus the three-analyst average estimate of $4.46 million.

  • Revenues by Segment- BetterHelp- Therapy Services: $263.71 million compared to the $261.88 million average estimate based on three analysts.

  • Revenue by Type- Other: $88.96 million versus $82.25 million estimated by two analysts on average.

  • Revenue by Type- Access fees: $557.17 million compared to the $555.17 million average estimate based on two analysts.

  • Adjusted EBITDA- BetterHelp: $15.47 million versus $15.44 million estimated by four analysts on average.

View all Key Company Metrics for Teladoc here>>>

Shares of Teladoc have returned -10.1% over the past month versus the Zacks S&P 500 composite's -3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research